SIPONIMOD and HEADACHE

Overview

HEADACHE is the #2 most commonly reported adverse reaction for SIPONIMOD, manufactured by Novartis Pharmaceuticals Corporation. There are 877 FDA adverse event reports linking SIPONIMOD to HEADACHE. This represents approximately 4.6% of all 19,111 adverse event reports for this drug.

Patients taking SIPONIMOD who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

HEADACHE is moderately reported among SIPONIMOD users, representing a notable but not dominant share of adverse events.

Other Side Effects of SIPONIMOD

In addition to headache, the following adverse reactions have been reported for SIPONIMOD:

• FATIGUE — 980 reports
• DIZZINESS — 664 reports
• GAIT DISTURBANCE — 527 reports
• MULTIPLE SCLEROSIS RELAPSE — 521 reports
• FALL — 496 reports
• MULTIPLE SCLEROSIS — 475 reports
• DRUG INEFFECTIVE — 415 reports
• NAUSEA — 406 reports
• LYMPHOCYTE COUNT DECREASED — 403 reports
• PRODUCT DOSE OMISSION ISSUE — 389 reports

Other Drugs Associated with HEADACHE

The following drugs have also been linked to headache in FDA adverse event reports:

Does SIPONIMOD cause HEADACHE?

HEADACHE has been reported as an adverse event in 877 FDA reports for SIPONIMOD. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is HEADACHE with SIPONIMOD?

HEADACHE accounts for approximately 4.6% of all adverse event reports for SIPONIMOD, making it one of the most commonly reported side effect.

What should I do if I experience HEADACHE while taking SIPONIMOD?

If you experience headache while taking SIPONIMOD, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages